[Comparative costs study between ready-to-administer bag of gemcitabine and production in reconstitution unit].

DISCUSSION: Ready-to-administer bags of gemcitabine allow relevant coverage of manufacturing doses. The annual extra cost would reach 37,200€ for our establishment. But, it can be justified by expected benefits: safer medication circuit, saving time of pharmacy technician….
PMID: 29958654 [PubMed - as supplied by publisher]

Source: Bulletin du Cancer - June 26, 2018 Category: Cancer & Oncology Authors: Pouplin M, Lortal B Tags: Bull Cancer Source Type: research